Key Takeaways
- • Healthify, a Khosla Ventures-backed Indian healthtech startup, has completed an all-stock merger with US-based Berry Street, combining AI-driven nutrition technology with clinical infrastructure and insurance coverage in the American market.
- • The combined entity will operate under dual leadership with Healthify founder Tushar Vashisht and Berry Street founder Noah Kotlove as co-CEOs, retaining the Berry Street brand in the US while maintaining the Healthify name in India and other markets.
- • Berry Street brings 2,000+ clinicians and insurance infrastructure serving over 200,000 patients across all 50 US states, while Healthify contributes its AI assistant Ria and food-tracking capabilities backed by 40 million users globally; the combined platform will include nutrition therapy and GLP-1 drug integration.
- • The merger accelerates Healthify's US expansion following its October 2024 Series C funding round of $45 million (including $20 million fresh capital), led by Khosla Ventures and LeapFrog Investments, bringing total primary equity raised to approximately $125 million.
- • The transaction positions the combined company to capitalize on the growing GLP-1 drug market for diabetes and obesity treatment, with AI support enabling clinicians to focus on complex care while automation handles patient engagement between consultations.
Summary
Healthify, the Bengaluru-based healthtech startup backed by Khosla Ventures, has merged with Berry Street, a US nutrition-care platform, in an all-stock transaction announced on August 24, 2026. The merger combines Healthify's proprietary AI technology with Berry Street's established clinical network and insurance infrastructure, creating an integrated metabolic health platform designed to serve the expanding US market for nutrition-based care and GLP-1 drug management.
The combined company will operate under a dual-CEO structure, with Healthify founder Tushar Vashisht and Berry Street founder Noah Kotlove leading jointly. Operationally, the entity will retain the Berry Street brand for US operations while continuing to operate as Healthify in India and international markets. This geographic branding strategy reflects each platform's market positioning and existing customer recognition in their respective regions.
Berry Street contributes significant clinical and insurance-access advantages, including a network of more than 2,000 clinicians (registered dietitians, doctors, and nurse practitioners) and direct patient relationships spanning all 50 US states. The platform has served over 200,000 patients and offers nutrition therapy alongside GLP-1 drug management capabilities. Healthify brings its AI assistant Ria—which provides personalized nutritional guidance by analyzing data on nutrition, sleep, stress, and weight—along with food-tracking tools and a global user base exceeding 40 million. The combined platform positions AI as a bridge between patient touchpoints, enabling clinicians to concentrate on interventions requiring specialized expertise.
The transaction represents a strategic milestone in Healthify's US market expansion. The startup closed a $45 million Series C financing round in October 2024, including $20 million in fresh capital, led by Khosla Ventures and LeapFrog Investments, with participation from Claypond Capital (backed by Ranjan Pai). That round brought Healthify's total primary equity raised to approximately $125 million, with capital explicitly earmarked for US expansion and AI development. The Berry Street merger now provides the clinical infrastructure and insurance pathways necessary to execute this growth strategy. The timing also capitalizes on the expanding GLP-1 market, as demand for nutrition support among patients using these medications for diabetes and obesity continues to accelerate.
The combined company will operate under a dual-CEO structure, with Healthify founder Tushar Vashisht and Berry Street founder Noah Kotlove leading jointly. Operationally, the entity will retain the Berry Street brand for US operations while continuing to operate as Healthify in India and international markets. This geographic branding strategy reflects each platform's market positioning and existing customer recognition in their respective regions.
Berry Street contributes significant clinical and insurance-access advantages, including a network of more than 2,000 clinicians (registered dietitians, doctors, and nurse practitioners) and direct patient relationships spanning all 50 US states. The platform has served over 200,000 patients and offers nutrition therapy alongside GLP-1 drug management capabilities. Healthify brings its AI assistant Ria—which provides personalized nutritional guidance by analyzing data on nutrition, sleep, stress, and weight—along with food-tracking tools and a global user base exceeding 40 million. The combined platform positions AI as a bridge between patient touchpoints, enabling clinicians to concentrate on interventions requiring specialized expertise.
The transaction represents a strategic milestone in Healthify's US market expansion. The startup closed a $45 million Series C financing round in October 2024, including $20 million in fresh capital, led by Khosla Ventures and LeapFrog Investments, with participation from Claypond Capital (backed by Ranjan Pai). That round brought Healthify's total primary equity raised to approximately $125 million, with capital explicitly earmarked for US expansion and AI development. The Berry Street merger now provides the clinical infrastructure and insurance pathways necessary to execute this growth strategy. The timing also capitalizes on the expanding GLP-1 market, as demand for nutrition support among patients using these medications for diabetes and obesity continues to accelerate.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.